Navigating the UPC: Infringement and injunctions in global pharma patent disputes

The Unified Patent Court (UPC) is changing the game for pharma patent litigation in Europe. With its cross-border reach and fast-moving procedures, it’s more important than ever for pharma IP teams to stay ahead of the curve.

We’re hosting a short, practical webinar to unpack some of the most pressing issues pharma companies are facing under the UPC: 

What we’ll cover: 

• second medical use infringement: where the risks are  
• imminent infringement: what it means in a pharma context 
• preliminary injunctions: key developments and strategic takeaways.

Your hosts and speakers:

Leading patent litigators Amanda Ebbutt, Jules Fabre and Gisbert Hohagen will share insights from recent UPC cases and what they mean for your enforcement strategy. 

The session will be hosted by Paul England.